Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Here is the first of the awaited podcasts from Dr. Natasha Leighl's presentation on "Highlights in Lung Cancer from 2012". Dr. Leighl is a longtime friend who is a lung cancer expert at Princess Margaret Hospital in Toronto, Ontario, Canada, and she covered a wide range of topics that represented promising developments in the field for the past year, some of which likely to lead to new treatment options for patients in the clinic over the next few years.
The first part of her talk covered new information on potential treatment options for patients with advanced NSCLC that has an activating EGFR mutation. Here's the video and audio versions of the podcast, along with the figures for it. (We're going to forgo the transcript, since it's a time-consuming process, and I don't think there's a major audience for it -- tell us if there's a clear need for the transcripts for these programs that we're not seeing).
[powerpress]
Dr. Leighl Highlights in LC 2012: Pt 1 EGFR Mutn Pos Audio Podcast
Dr. Leighl Highlights in LC 2012 Pt 1 EGFR Mutn Pos Figures
We've got more parts of her presentation waiting in the wings, so check back for more highlights in lung cancer soon.
Please feel free to offer comments and raise questions in our
discussion forums.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.